The Scientific Advisory Team at Alzheon consists of a group of leading experts who provide strategic guidance and expertise on the scientific research and development of innovative medicines targeting neurodegenerative disorders. They play a critical role in aligning the company’s efforts with the latest advancements in scientific knowledge and clinical practices.
Carmela R. Abraham
Scientific Advisor
Cyril Höschl
Scientific Advisor
Jakub Hort
Scientific Advisor
Kaj Blennow
Scientific Advisor
Keith Crutcher
Scientific Advisor
Louis Kirby
Scientific Advisor
Miia Kivipelto
Scientific Advisor
Serge Gauthier
Scientific Advisor
Steven Jacobsen
Scientific Advisor
William Mobley
Scientific Advisor
View all